Attached files

file filename
10-K - FORM 10-K - BIO-TECHNE Corptech20200630b_10k.htm
EX-32.2 - EXHIBIT 32.2 - BIO-TECHNE Corpex_248818.htm
EX-32.1 - EXHIBIT 32.1 - BIO-TECHNE Corpex_248817.htm
EX-31.2 - EXHIBIT 31.2 - BIO-TECHNE Corpex_248816.htm
EX-31.1 - EXHIBIT 31.1 - BIO-TECHNE Corpex_248815.htm
EX-21 - EXHIBIT 21 - BIO-TECHNE Corpex_248813.htm
EX-10.11 - EXHIBIT 10.11 - BIO-TECHNE Corpex_248812.htm
EX-10.10 - EXHIBIT 10.10 - BIO-TECHNE Corpex_248811.htm
EX-10.9 - EXHIBIT 10.9 - BIO-TECHNE Corpex_248810.htm
EX-10.8 - EXHIBIT 10.8 - BIO-TECHNE Corpex_248809.htm
EX-10.7 - EXHIBIT 10.7 - BIO-TECHNE Corpex_248808.htm
EX-10.6 - EXHIBIT 10.6 - BIO-TECHNE Corpex_248807.htm
EX-10.5 - EXHIBIT 10.5 - BIO-TECHNE Corpex_248806.htm
EX-10.4 - EXHIBIT 10.4 - BIO-TECHNE Corpex_248805.htm
EX-10.3 - EXHIBIT 10.3 - BIO-TECHNE Corpex_248804.htm
EX-4.1 - EXHIBIT 4.1 - BIO-TECHNE Corpex_248803.htm

Exhibit 23

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the registration statements (Nos. 333-37263, 333-88885, 333-49962, 333-170576, 333-199847, 333-207710, 333-221143, and 333-249974) on Form S-8 of our reports dated August 25, 2021, with respect to the consolidated financial statements of Bio-Techne Corporation and the effectiveness of internal control over financial reporting.

 

/s/ KPMG LLP

 

Minneapolis, Minnesota

August 25, 2021